Ye Yang

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

NAT10-Mediated ac4C Modification of circANKRD12 Reprograms the Tumor Microenvironment.

NAT10-Mediated ac4C Modification of circANKRD12 Reprograms the Tumor Microenvironment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 30, 2026

Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol-Inspired Approach.

Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol-Inspired Approach.

Journal: Basic & clinical pharmacology & toxicology

Published: January 20, 2026

Exploring the applicability, combined strategies, and challenges of ablation in hematology based on its characteristics and immunomodulatory mechanisms.

Exploring the applicability, combined strategies, and challenges of ablation in hematology based on its characteristics and immunomodulatory mechanisms.

Journal: Clinical and experimental medicine

Published: October 05, 2025

B4GALT3 as a Key Glycosyltransferase Gene in Multiple Myeloma Progression: Insights From Bioinformatics, Machine Learning, and Experimental Validation.

B4GALT3 as a Key Glycosyltransferase Gene in Multiple Myeloma Progression: Insights From Bioinformatics, Machine Learning, and Experimental Validation.

Journal: Molecular carcinogenesis

Published: February 27, 2025

Mechanisms and targeted prevention of hepatic osteodystrophy caused by a low concentration of di-(2-ethylhexyl)-phthalate.

Mechanisms and targeted prevention of hepatic osteodystrophy caused by a low concentration of di-(2-ethylhexyl)-phthalate.

Journal: Frontiers in immunology

Published: December 27, 2024

Overcoming cancer therapy resistance: From drug innovation to therapeutics.

Overcoming cancer therapy resistance: From drug innovation to therapeutics.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: December 26, 2024

Bruceine A Inhibits Cell Proliferation by Targeting the USP13/PARP1 Signalling Pathway in Multiple Myeloma.

Bruceine A Inhibits Cell Proliferation by Targeting the USP13/PARP1 Signalling Pathway in Multiple Myeloma.

Journal: Basic & clinical pharmacology & toxicology

Published: November 18, 2024

Targeting the Liquid-Liquid Separation Region of c-Maf for Treating Chromosomal Translocations in Multiple Myeloma.

Targeting the Liquid-Liquid Separation Region of c-Maf for Treating Chromosomal Translocations in Multiple Myeloma.

Journal: MedComm

Published: November 03, 2024

The release of NETs during SFTSV infection downregulates the specific inflammatory factors that lead to liver and spleen damage.

The release of NETs during SFTSV infection downregulates the specific inflammatory factors that lead to liver and spleen damage.

Journal: Journal of leukocyte biology

Published: October 08, 2024

Exploring the landscape of post-translational modification in drug discovery.

Exploring the landscape of post-translational modification in drug discovery.

Journal: Pharmacology & therapeutics

Published: July 21, 2024

PNPO-Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β-Catenin Pathway.

PNPO-Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β-Catenin Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 08, 2024

Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.

Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.

Journal: Journal of medicinal chemistry

Published: March 14, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026